Urology eLearning Workshop; A guide to NMIBC - Module 4 Administration and reconstitution of intravesical chemotherapy
About the CPD course
This is the fourth module of an eLearning course which features 6 interactive modules; covering a full range of topics within non-muscle invasive bladder cancer. When you finish this module; you should have an awareness of; The core competencies required for the administration of intravesical chemotherapy for bladder cancer; How to promote patient welfare; How intravesical chemotherapy is administered; Post-operatively; immediately after TURBT (trans-urethral resection of bladder tumour); and Later on in the outpatient department; as a continuing course of treatment; Safe handling and disposal of cytotoxic agents; Key stages of documentation; Your role in ensuring continuity of care.
medac Pharma is a privately owned, pharmaceutical company specialising in the development, diagnosis and treatment of diseases within the key areas of oncology, urology, haematology and autoimmune. The company was originally founded in Germany in 1970 and the UK operation was established in 1993. Since then we have become known for developing innovative products from standard cancer chemotherapy to niche speciality medicines.